Musculoskeletal Infection

Clinically relevant assessment of novel antimicrobial interventions


Dr T Fintan Moriarty

Focus Area Leader

Musculoskeletal infections are among the most challenging complications associated with the surgical fixation of fractures. The Musculoskeletal Infection group performs research into two clinically important aspects of musculoskeletal infection:

  • The development of in vivo models of musculoskeletal infection that are clinically relevant and appropriate for studies into the prevention, treatment, or pathophysiology of these infections;
  • Novel interventional strategies against musculoskeletal infection, including novel local antimicrobial delivery vehicles.


Our expertise includes bacterial and biofilm culture, in vitro assessment of antibacterial efficacy, and numerous preclinical in vivo models of infection that may be performed under Good Laboratory Practice (GLP) principles.

Focus areas

Meet the team

See more about the team on the Musculosketelal Infection group page

Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.